pharmacogenomics
Also, Standigm has partnered with Merck Korea for AI drug discovery research.
Joel Diamond, MD, CMO of 2bPrecise, discusses pharmacogenomics as a good entry point for providers in precision medicine, identifying the right medicine for better outcomes and patient satisfaction.